Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.

< BACK TO ARCHIVE


2021 Jul 15


Influenza Other Respir Viruses


http://www.ncbi.nlm.nih.gov/pubmed/34264010?dopt=Abstract

Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.

Authors

Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt.
El Rifay AS, Mahmoud SH, Marouf MA, Gomaa MR, El Taweel A, Abo Shama NM, GabAllah M, Abd El Dayem SM, Kandeil A, Mostafa A, El-Shesheny R, Kayali G, Ali MA
Influenza Other Respir Viruses. 2021 Jul 15.
PMID: 34264010.

Abstract

Reported laboratory-confirmed COVID-19 cases underestimate the true burden of disease as cases without laboratory confirmation, and asymptomatic and mild cases are missed by local surveillance systems. Population-based seroprevalence studies can provide better estimates of burden of disease by taking into account infections that were missed by surveillance systems. Additionally, little is known about the determinants of seroconversion in community settings.
Read This Paper